Figure 3.

Commercially launched FLORIGENE Moon series transgenic carnations accumulating delphinidin-based anthocyanins by expressing heterologous F3′5′H genes. The flowers have novel blue/violet colours and accumulate various amounts of delphinidin-derived anthocyanins in their petals resulting in differing petal shades. Binary vector numbers (italic) and commercial names are shown (refer to table 2 for description). Phenotypes of these lines are stable. A flower arrangement consisting of the transgenic carnations is also shown.